123 related articles for article (PubMed ID: 6075896)
1. [Long-term treatment of previously therapy-resistant cases of primary hypertriglyceridemia of the adult with ethyl-p-chlorophenoxyisobutyrate].
Braunsteiner H; Herbst M; Sandhofer F; Sailer S
Dtsch Med Wochenschr; 1967 Dec; 92(50):2302-8. PubMed ID: 6075896
[No Abstract] [Full Text] [Related]
2. Atromid-S for the reduction of plasma lipids.
Med Lett Drugs Ther; 1967 Jun; 9(12):45-7. PubMed ID: 6037633
[No Abstract] [Full Text] [Related]
3. Long-term therapy of adult cases of primary hypertriglyceridaemia with clofibrate (ethyl-p-chlorophenoxyisobutyrate).
Braunsteiner H; Herbst M; Sandhofer F; Sailer S
Ger Med Mon; 1968 Feb; 13(2):65-72. PubMed ID: 5653144
[No Abstract] [Full Text] [Related]
4. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
[No Abstract] [Full Text] [Related]
5. [Clinical-experimental studies on lipid metabolism using Regelan].
Hammerl H
Wien Klin Wochenschr; 1967 Sep; 79(39):720-2. PubMed ID: 4875575
[No Abstract] [Full Text] [Related]
6. [Experience with 110 medium-length therapeutic trials of ethyl chlorophenoxyisobutyrate with or without androsterone in various types of idiopathic hyperlipidemia].
De Gennes JL; Maunand B; Salmon D; Laudat P; Truffert J
Rev Atheroscler (Paris); 1966; 8(1):27-52. PubMed ID: 5961027
[No Abstract] [Full Text] [Related]
7. Treatment of hyperlipidemia with the ethyl-ester of chlorophenoxyisobutyrate and androsterone.
Schatz IJ
Henry Ford Hosp Med J; 1965 Dec; 13(4):447-56. PubMed ID: 5325188
[No Abstract] [Full Text] [Related]
8. Clinical trial with ethyl-a-p-chlorophenoxyisobutyrate (Atromid-S) with special reference to white blood cell counts.
Engström J
Acta Med Scand; 1966 Nov; 180(5):519-31. PubMed ID: 5332263
[No Abstract] [Full Text] [Related]
9. Observations on the effect of ethyl a-p chlorophenoxyisobutyrate (CPIB) therapy on serum lipid levels and on diabetic and some other retinopathies.
Vannas S; Esilä R; Tuovinen E
Acta Ophthalmol (Copenh); 1968; 46(2):162-70. PubMed ID: 5755673
[No Abstract] [Full Text] [Related]
10. Divergent effects in the treatment of hyperlipemia.
Slowe IA; Carter AC; Feldman EB
Arch Intern Med; 1965 Oct; 116(4):523-30. PubMed ID: 5835355
[No Abstract] [Full Text] [Related]
11. [Action mechanism and clinical success of Regelan (Clofibrate)].
Fitzgerald JD
Wien Klin Wochenschr; 1967 Sep; 79(39):716-20. PubMed ID: 5595437
[No Abstract] [Full Text] [Related]
12. [Clinical experimentation with CPIB (with or without androsterone) in the treatment of hyperlipemia. Apropos of 35 cases].
Warembourg H; Jaillard J
Lille Med; 1965 Apr; 10(4):431-6. PubMed ID: 5318637
[No Abstract] [Full Text] [Related]
13. A controlled trial of Atromid therapy in exudative diabetic retinopathy.
Cullen JF; Ireland JT; Oliver MF
Trans Ophthalmol Soc U K (1962); 1964; 84():281-95. PubMed ID: 5227423
[No Abstract] [Full Text] [Related]
14. Clofibrate and androsterone effect on serum lipids.
Orgain ES; Bogdonoff MD; Cain C
Arch Intern Med; 1967 Jan; 119(1):80-5. PubMed ID: 6015838
[No Abstract] [Full Text] [Related]
15. [Studies on lipemia in elderly persons and the lipid lowering effect of a clofibrate derivate in 2 groups of test persons].
Rilliet B; Monnier J
Praxis; 1969 Jun; 58(25):815-20. PubMed ID: 5819485
[No Abstract] [Full Text] [Related]
16. [Therapy of primary hyperlipemias].
Schlierf G; Kahlke W
Dtsch Med Wochenschr; 1969 Feb; 94(7):329-32. PubMed ID: 5762992
[No Abstract] [Full Text] [Related]
17. Hypolipidemic effect of chlorophenoxyisobutyrate in adult-onset diabetes mellitus.
Danowski TS; Novak JF; Saul RW; Vester JW; Moses C
Clin Pharmacol Ther; 1966; 7(5):631-8. PubMed ID: 5957168
[No Abstract] [Full Text] [Related]
18. [Association of neomycin sulfate and ethyl-p-chlorophenoxybutyrate in the treatment of dyslipemia].
Bertulla A; Bertamino V; Solari E
Ateneo Parmense 1; 1971; 42(2):103-14. PubMed ID: 5154400
[No Abstract] [Full Text] [Related]
19. [Action of ethyl chlorophenoxyisobutyrate on several types of hyperlipidemia].
Beaumont V; Swynghedauw B; Beaumont JL; Himbert J
Rev Atheroscler (Paris); 1966; 8(1):12-20. PubMed ID: 5961026
[No Abstract] [Full Text] [Related]
20. Hypolipidemic agents--newly approved.
Duncan GG
Pa Med; 1967 Aug; 70(8):75-6. PubMed ID: 6073724
[No Abstract] [Full Text] [Related]
[Next] [New Search]
